Clinical Trial Update: Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the addition of gemcitabine to pre-allo-HSCT conditioning in adults with acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Acute Lymphoblastic Leukemia, Adult | Phase 2 | Status: UNKNOWN